A study published in the journal Human Reproduction says that almost 20% of French Men are falling short of sperms that are required to get woman pregnant.
As per the findings of the study, a decline of 32.3% has been reported in the sperm count in French men since 1989, which means on an average 1.9% decrease was recorded each year. However, the number of what doctors call "normally shaped sperms" fell down by 33.4%.
The results were derived from the tests, which were conducted on semen samples taken from 26,600 men from over the France who participated in the study. The researchers deemed that the finding are alarming and are raising a serious concern.
Describing the results as a serious health warning, Dr. Joelle Le Moal, co-author of the study, said the matter required probe into the reasons and fix them at the earliest.
"We still do not know which are most important factors, but perhaps the most likely is a combination such as a high-fat diet combined with increased environmental chemical exposures", said the Professor Richard Sharpe, from the University of Edinburgh as he blamed the modern life style for the cause.
Other countries to report similar findings are New Zealand, India, Tunisia and Israel, quoted Reuters.
In a recent announcement, Sega has revealed that its Steam catalog of classic Genesis and Mega Drive games is being updated with a new 3D interface --- the Sega Mega Drive Classics Hub.
Announcing the Classics Hub, Sega said that the new...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
Electric vehicle manufacturer Tesla has said in a recent announcement that it is now offering free trials of its autopilot software on Model S and Model X cars. The free trials give the owners of Model S and Model X cars a chance to test...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google has revealed in a recent announcement that its latest Nik Collection of photo...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Wednesday, European competition authorities unveiled...
The button white mushroom edited using CRISPR has...
In a Tuesday announcement, Supergiant Games studio’s...
According to a CNN report, the Federal Investigation...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).